Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
241
-
Total 13F shares, excl. options
-
45M
-
Shares change
-
+75.8K
-
Total reported value, excl. options
-
$1.69B
-
Value change
-
-$4.08M
-
Put/Call ratio
-
0.51
-
Number of buys
-
84
-
Number of sells
-
-118
-
Price
-
$37.46
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q3 2019
298 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q3 2019.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 241 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45M shares
of 46.1M outstanding shares and own 97.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.58M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.56M shares), VANGUARD GROUP INC (4.52M shares), Champlain Investment Partners, LLC (2.58M shares), VICTORY CAPITAL MANAGEMENT INC (2.33M shares), DIMENSIONAL FUND ADVISORS LP (2.28M shares), Paradice Investment Management LLC (2.25M shares), WELLINGTON MANAGEMENT GROUP LLP (2.09M shares), STATE STREET CORP (1.78M shares), and Invesco Ltd. (1.64M shares).
This table shows the top 241 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.